Clinical Trial Update: Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for intravenous T3011 as a single agent and in combination therapy in advanced solid tumors including hepatocellular carcinoma, with Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Endometrial Cancer
• Hepatocellular Carcinoma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Solid Tumor

Snippet

Sponsor: ImmVira Pharma Co. Ltd | Conditions: Solid Tumor, Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN